Patents

US 11993581 B2: Pyridazine compounds for inhibiting Nav1.8

Granted
2024-05-28
Filed
2019-07-09 application 17256784
Type
Utility · 14 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Pyridazine compounds for inhibiting NaV1.8 and methods for treating a condition, disease, or disorder associated with an increased NaV1.8 activity or expression are disclosed.

Source: PVGPATDIS, file of 2026-04-10 (ipg240528.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Lieber Institute, Inc. 9 patentsUS company or organizationBaltimore, MDLIEBER INSTITUTE INC Nonprofit EXACT high confidence: identical full name and statePVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Michael S. PoslusneyOwings Mills, MD16PVGPATDIS, file of 2026-04-10
Glen ErnstBear, DE11PVGPATDIS, file of 2026-04-10
James C. BarrowArnold, MD29PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P29/00PVGPATDIS, file of 2026-04-10
C07DHeterocyclic compoundsC07D401/12PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2024-05-29Correction
Corrective assignment to correct the correct the misspelling of assignee name from lieber institue, inc to lieber institute, inc. previously recorded at reel: 56249 frame: 634. assignor(s) hereby confirms the assignment.
BARROW, JAMES signed 2018-08-16
ERNST, GLEN signed 2018-08-16
POSLUSNEY, MICHAEL signed 2018-08-16
LIEBER INSTITUTE, INC BALTIMORE, MD67558/336ECORSEXC, file of 2026-09-25
2021-05-14Assignment
Assignment of assignor's interest
BARROW, JAMES signed 2018-08-16
ERNST, GLEN signed 2018-08-16
POSLUSNEY, MICHAEL signed 2018-08-16
LIEBER INSTITUE, INC BALTIMORE, MD56249/634ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.